OrbiMed's mutual fund business was launched in 1989 to invest on a worldwide basis in biotechnology and pharmaceutical companies. As one of the largest and oldest asset management firms dedicated to the health sciences sector, OrbiMed has the scale, resources and experience necessary to seek out promising investment opportunities. We manage two primary mutual funds for individual investors:

Eaton Vance Worldwide Health Sciences Fund.

A publicly-offered open-end mutual fund which seeks superior biotechnology and pharmaceutical investment opportunities on a worldwide basis.

More detailed information about this fund, including a fund prospectus, is available on the Eaton Vance website or by calling (800) 262-1122 from the United States.

Finsbury Worldwide Pharmaceutical Trust PLC.

This Trust seeks superior pharmaceutical and biotechnology investment opportunities on a worldwide basis. The Trust was launched in 1995, and is a closed-end UK Investment Trust which trades on the London Stock Exchange.

More detailed information about this Trust is available on the Frostrow Capital website or by calling +44 (0) 203 0084910.

We appreciate your interest in our firm and investment funds.

   Back to Funds